ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,709Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 288

$864K Total Retail Price of All Prescriptions

Rank: 4 out of 288

477 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 477 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

23% of this provider’s 477 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 10,037 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 811 527 1 1
HYDROCODONE-ACETAMINOPHEN 555 426 S3 2 3
OMEPRAZOLE 402 225 3 4
LEVOTHYROXINE SODIUM 370 301 4 2
FUROSEMIDE 325 293 5 8
CITALOPRAM HBR 319 252 6 12
METFORMIN HCL 318 234 7 6
TRAZODONE HCL 304 236 8 13
RISPERIDONE 295 253 9 40
HYDROCHLOROTHIAZIDE 280 195 10 9
AMLODIPINE BESYLATE 262 213 11 7
EXELON 260 260 12 90
POTASSIUM CHLORIDE 201 179 13 18
CRESTOR 200 130 14 46
DONEPEZIL HCL 190 190 15 29
CARVEDILOL 183 108 16 27
NAMENDA 178 178 17 30
DIVALPROEX SODIUM 166 119 18 32
CARBIDOPA-LEVODOPA 165 111 19 71
OXYCODONE-ACETAMINOPHEN 147 100 S2 20 53
SIMVASTATIN 140 105 21 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 137 69 22 55
PROAIR HFA 137 84 22 26
WARFARIN SODIUM 123 123 24 11
ZOLPIDEM TARTRATE 122 88 25 24
FENTANYL 122 100 S2 25 49
LOVASTATIN 116 71 27 14
OXYCODONE HCL 111 69 S2 28 17
ATENOLOL 108 66 29 15
CIPROFLOXACIN HCL 107 92 30 85
BACLOFEN 104 37 31 54
RANITIDINE HCL 104 92 31 35
ADVAIR DISKUS 103 74 33 38
GABAPENTIN 103 53 33 10
MONTELUKAST SODIUM 95 55 35 143
SPIRIVA 95 78 35 44
JANUVIA 94 70 37 107
LANTUS 94 77 37 47
METOPROLOL SUCCINATE 92 73 39 20
SINGULAIR 92 62 39 115
IBUPROFEN 91 17 41 41
SERTRALINE HCL 89 66 42 23
PHENYTOIN SODIUM EXTENDED 88 30 43 119
OXYBUTYNIN CHLORIDE 85 31 44 147
TRAMADOL HCL 85 34 44 31
PAROXETINE HCL 85 44 44 52
TRIAMCINOLONE ACETONIDE 84 68 47 64
QUETIAPINE FUMARATE 84 84 47 42
AZITHROMYCIN 73 49 49 77
METOPROLOL TARTRATE 72 66 50 15
POLYETHYLENE GLYCOL 3350 71 54 51 48
OPANA ER 70 43 S2 52 153
CYMBALTA 67 49 53 28
ESCITALOPRAM OXALATE 67 42 53 61
TAMSULOSIN HCL 65 64 55 50
BYSTOLIC 64 51 56 159
NOVOLOG 64 64 56 124
GEMFIBROZIL 61 49 58 69
FLUOXETINE HCL 60 54 59 36
BENZTROPINE MESYLATE 55 15 R 60 130
AMITRIPTYLINE HCL 55 18 R 60 45
LOSARTAN POTASSIUM 54 43 62 19
OXYBUTYNIN CHLORIDE ER 51 32 63 193
MIRTAZAPINE 50 47 64 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 25, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.